It's official. Cardinal PTS becomes Catalent Pharma Solutions
Catalent Pharma Solutions, formerly Cardinal Health Pharmaceutical Technologies and Services, has launched as an independent company after completing The Blackstone Group's $3.3 billion acquisition of the business from Cardinal Health in April 2007. The name 'Catalent' combines ideas inherent in the words 'catalyst' and 'talent.'
Catalent inherits the legacy of dosage form innovation, having commercialised softgel capsule technology and Liqui-Gel formulations, created the "fast dissolve" oral tablet category with Zydis, and introduced the vegetable-based capsule VegiCaps Soft. The company is also recognised for its child-resistant, senior-friendly and compliance-enhancing packaging designs.
John Lowry, President and CEO of Catalent Pharma Solutions perceives Catalent as providing customers with technologies, services and reliable solutions, "enabling them to focus on their own core competencies."
Keywords : Cardinal PTS, Outsourcing services, Catalent Pharma Solutions, Blackstone Group, Acquisition, Contract Manufacturing
